Extracellular and intracellular anti-mutagenic effects of bile pigments in the Salmonella typhimurium reverse mutation assay

Toxicology in Vitro

Volumn 27, Issue 1, 2013, Pages 433-437

  Molzer C ^a   Huber, H ^a   Diem, K ^a   Wallner, M ^a   Bulmer, A C ^b   Wagner, K H ^a,b  

^a UNIVERSITY OF VIENNA   (Austria)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

Bilirubin; Biliverdin; Cancer; Frame shift; TA102; TA98

Indexed keywords

BILE PIGMENT; BILIRUBIN; BILIRUBIN GLUCURONIDE; BILIVERDIN; ANTIMUTAGENIC AGENT; MUTAGENIC AGENT;

ARTICLE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM COLONY; CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXTRACELLULAR SPACE; FRAMESHIFT MUTATION; GENOTOXICITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; INTRACELLULAR SPACE; MUTAGENESIS; MUTATIONAL ANALYSIS; NONHUMAN; SALMONELLA TYPHIMURIUM; DRUG EFFECT; GENETICS; METABOLISM; MUTAGEN TESTING; MUTATION;

BACTERIA (MICROORGANISMS); SALMONELLA TYPHIMURIUM;

ANTIMUTAGENIC AGENTS; BILE PIGMENTS; BILIRUBIN; BILIVERDINE; MUTAGENICITY TESTS; MUTAGENS; MUTATION; SALMONELLA TYPHIMURIUM;

EID: 84884198470     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2012.08.004     Document Type: Article

References (22)

1. Asad, S.F., Singh, S., Ahmad, A., Khan, N.U., Hadi, S.M., 2001. Prooxidant and antioxidant activities of bilirubin and its metabolic precursor biliverdin: a structure-activity study. Chem. Biol. Interact. 137, 59-74.
2. Boon, A.C., Hawkins, C.L., Bisht, K., Coombes, J.S., Bakrania, B., Wagner, K.H., Bulmer, A.C., 2012. Reduced circulating oxidized LDL is associated with hypocholesterolemia and enhanced thiol status in Gilbert syndrome. Free Radic. Biol. Med. 52, 2120-2127.
3. Bradford, M.M., 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
4. Brower, J.O., Lightner, D.A., McDonagh, A.F., 2001. Aromatic congeners of bilirubin: synthesis, stereochemistry, glucuronidation and hepatic transport. Tetrahedron 57, 7813-7827.
5. Bulmer, A.C., Blanchfield, J.T., Coombes, J.S., Toth, I., 2008a. In vitro permeability and metabolic stability of bile pigments and the effects of hydrophilic and lipophilic modification of biliverdin. Bioorg. Med. Chem. 16, 3616-3625.
6. Bulmer, A.C., Blanchfield, J.T., Toth, I., Fassett, R.G., Coombes, J.S., 2008b. Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection. Atherosclerosis 199, 390-396.
7. Bulmer, A.C., Coombes, J.S., Blanchfield, J.T., Toth, I., Fassett, R.G., Taylor, S.M., 2011. Bile pigment pharmacokinetics and absorption in the rat: therapeutic potential for enteral administration. Br. J. Pharmacol. 164, 1857-1870.
8. Bulmer, A.C., Ried, K., Coombes, J.S., Blanchfield, J.T., Toth, I., Wagner, K.H., 2007. The anti-mutagenic and antioxidant effects of bile pigments in the Ames Salmonella test. Mutat. Res. 629, 122-132.
9. Guengerich, F.P., 2000. Metabolism of chemical carcinogens. Carcinogenesis 21, 345-351.
10. Hayatsu, H., 1995. Complex formation of heterocyclic amines with porphyrins: its use in detection and prevention, Princess Takamatsu Symposium, 1995/01/01 ed, pp. 172-180.
11. Horsfall, L.J., Rait, G., Walters, K., Swallow, D.M., Pereira, S.P., Nazareth, I., Petersen, I., 2011. Serum bilirubin and risk of respiratory disease and death. JAMA 305, 691-697.
12. Keshavan, P., Schwemberger, S.J., Smith, D.L., Babcock, G.F., Zucker, S.D., 2004. Unconjugated bilirubin induces apoptosis in colon cancer cells by triggering mitochondrial depolarization. Int. J. Cancer 112, 433-445.
13. Kim, Y.R., Chung, N.G., Kang, M.R., Yoo, N.J., Lee, S.H., 2010. Novel somatic frameshift mutations of genes related to cell cycle and DNA damage response in gastric and colorectal cancers with microsatellite instability. Tumori 96, 1004-1009.
14. Klatskin, G., 1961. Bile pigment metabolism. Annu. Rev. Med. 12, 211-250.
15. Konickova, R., Jiraskova, A., Zelenka, J., Leseticky, L., Sticha, M., Vitek, L., 2012. Reduction of bilirubin ditaurate by the intestinal bacterium Clostridium perfringens. Acta. Biochim. Pol. 59, 289-292.
16. MacLean, P.D., Chapman, E.E., Dobrowolski, S.L., Thompson, A., Barclay, L.R., 2008. Pyrroles as antioxidants: solvent effects and the nature of the attacking radical on antioxidant activities and mechanisms of pyrroles, dipyrrinones, and bile pigments. J. Org. Chem. 73, 6623-6635.
17. Maron, D.M., Ames, B.N., 1983. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 113, 173-215.
18. McCarty, M.F., 2007. "Iatrogenic Gilbert syndrome"-a strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubin. Med. Hypotheses 69, 974-994.
19. Mortelmans, K., Zeiger, E., 2000. The Ames Salmonella/microsome mutagenicity assay. Mutat. Res. 455, 29-60.
20. Turesky, R.J., Guengerich, F.P., Guillouzo, A., Langouet, S., 2002. Metabolism of heterocyclic aromatic amines by human hepatocytes and cytochrome P4501A2. Mutat. Res. 506-507, 187-195.
21. Wallner, M., Blassnigg, S.M., Marisch, K., Pappenheim, M.T., Müllner, E., Mölzer, C., Nersesyan, A., Marculescu, R., Doberer, D., Knasmüller, S., Bulmer, A.C., Wagner, K.-H., 2012. Effects of unconjugated bilirubin on chromosomal damage in individuals with Gilbert's syndrome measured with the micronucleus cytome assay. Mutagenesis, in press. http://dx.doi.org/10.1093/mutage/ges039.
22. Zucker, S.D., Horn, P.S., Sherman, K.E., 2004. Serum bilirubin levels in the U.S. population: gender effect and inverse correlation with colorectal cancer. Hepatology 40, 827-835.